Search

everythinglearnresearchcommunity

for

Search:↓

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Stopping the use of fluocinolone oil containing balsam fragrance improved hair regrowth in children allergic to it.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Iron deficiency might contribute to hair loss in women.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Vascular endothelial cells may significantly influence skin stem cells, but more research is needed.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Brazilian patients with inflammatory bowel disease have a high rate of skin problems compared to healthy people.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

The MPV/PC ratio can help assess disease activity in alopecia areata.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Elderly skin care needs personalized treatment, early intervention, and integrated psychiatric care.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.